Following the recent clearance of its FreeStyle Lite® blood glucose test strips, Abbott announced that it has also received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle blood glucose test strips. The new FreeStyle test strips minimize interference during blood glucose testing and are designed to offer a better testing experience.
In a similar fashion to the FreeStyle Lite blood glucose test strips, the new FreeStyle test strips do not use the GDH-PQQ(1) enzyme, which can be affected by common non-glucose sugars. The new FreeStyle test strips use a GDH-FAD(2) enzyme which is unaffected by common non-glucose sugars, such as maltose or galactose, and minimizes the potential for other interference.
